Taro Pharmaceutical Industries Ltd (NYSE:TARO)

89.24
Delayed Data
As of Jun 14
 -0.26 / -0.29%
Today’s Change
76.93
Today|||52-Week Range
109.42
+5.43%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close89.50
Today’s open88.91
Day’s range88.63 - 89.56
Volume34,533
Average volume (3 months)71,556
Market cap$3.5B
Data as of 4:02pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)+37.39%
Earnings growth (this year)+24.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.21%
P/E ratio11.3
Price/Sales6.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-1.37-5.35%
RGENRepligen Corp-0.76-1.01%
HCMHutchison China Medi...-0.74-2.74%
ALKSAlkermes Plc-0.52-2.32%
Data as of 4:00pm ET, 06/14/2019

Financials

Next reporting dateAugust 8, 2019
EPS forecast (this quarter)$2.57
Annual revenue (last year)$669.9M
Annual profit (last year)$281.8M
Net profit margin42.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Head-Operations
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts